Home > NRC Library > ADAMS Public Documents

Ack receipt of response to NRC 891019 telcon request re allegations pertaining to univ use of I-131.Use of I-131 on pediatric patient in accordance w/NRC byproduct license & submitted protocol to FDA.Info re addl allegations encl.

Accession Number: ML20005G398

Date Released: Thursday, October 24, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20005G397 - Ack receipt of response to NRC 891019 telcon request re allegations pertaining to univ use of I-131.Use of I-131 on pediatric patient in accordance w/NRC byproduct license & submitted protocol to FDA.Info re addl allegations encl. (2 page(s), 12/8/1989)
• ML20005G415 - Partially withheld ltr re patient treatment w/I-131 MIBG for end-stage neuroblastoma.Doses in line w/doses used by other research groups attempting similar therapies.Application to amend FDA license encl. (27 page(s), 10/13/1989)